This trial will see if eating only during an 8-10 hour window each day, without cutting calories, can improve how well cancer patients respond to immunotherapy.
2 Primary · 0 Secondary · Reporting Duration: at 3 months
Active Control
Experimental Treatment
52 Total Participants · 2 Treatment Groups
Primary Treatment: Prolonged Nightly Fasting · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: